PRAECIS PHARMACEUTICALS INC
10-Q, EX-27, 2000-06-07
PHARMACEUTICAL PREPARATIONS
Previous: PRAECIS PHARMACEUTICALS INC, 10-Q, EX-3.2, 2000-06-07
Next: PRAECIS PHARMACEUTICALS INC, 4, 2000-06-07



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED BALANCE SHEETS AND CONDENSED STATEMENTS OF OPERATIONS CONTAINED
IN THE COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED
MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIALS STATEMENTS AND THE NOTES THERETO.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          86,296
<SECURITIES>                                         0
<RECEIVABLES>                                    6,344
<ALLOWANCES>                                         0
<INVENTORY>                                     26,330
<CURRENT-ASSETS>                               131,417
<PP&E>                                           5,903
<DEPRECIATION>                                     633
<TOTAL-ASSETS>                                 137,320
<CURRENT-LIABILITIES>                           47,491
<BONDS>                                              0
                                0
                                         35
<COMMON>                                            70
<OTHER-SE>                                      89,882
<TOTAL-LIABILITY-AND-EQUITY>                   137,320
<SALES>                                              0
<TOTAL-REVENUES>                                 9,001
<CGS>                                                0
<TOTAL-COSTS>                                   12,670
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (2,375)
<INCOME-TAX>                                       100
<INCOME-CONTINUING>                            (2,475)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,475)
<EPS-BASIC>                                      (.36)
<EPS-DILUTED>                                    (.36)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission